AQR Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.33M Buy
1,402,210
+228,985
+20% +$217K ﹤0.01% 2030
2025
Q1
$541K Buy
+1,173,225
New +$541K ﹤0.01% 2388
2023
Q4
Sell
-29,558
Closed -$32.2K 2396
2023
Q3
$32.2K Buy
29,558
+1,501
+5% +$1.64K ﹤0.01% 2299
2023
Q2
$64.3K Buy
+28,057
New +$64.3K ﹤0.01% 2160
2023
Q1
Sell
-47,014
Closed -$89.8K 2220
2022
Q4
$89.8K Sell
47,014
-253,205
-84% -$484K ﹤0.01% 2148
2022
Q3
$721K Buy
+300,219
New +$721K ﹤0.01% 1646
2022
Q2
Sell
-47,677
Closed -$100K 2248
2022
Q1
$100K Sell
47,677
-71,597
-60% -$150K ﹤0.01% 2137
2021
Q4
$470K Sell
119,274
-84,085
-41% -$331K ﹤0.01% 1848
2021
Q3
$978K Sell
203,359
-121,645
-37% -$585K ﹤0.01% 1555
2021
Q2
$1.49M Buy
325,004
+85,817
+36% +$394K ﹤0.01% 1381
2021
Q1
$1.4M Buy
239,187
+117,784
+97% +$691K ﹤0.01% 1402
2020
Q4
$415K Sell
121,403
-521,750
-81% -$1.78M ﹤0.01% 1852
2020
Q3
$926K Sell
643,153
-561,880
-47% -$809K ﹤0.01% 1439
2020
Q2
$2.4M Sell
1,205,033
-238,403
-17% -$476K ﹤0.01% 1074
2020
Q1
$2.82M Buy
1,443,436
+854,990
+145% +$1.67M ﹤0.01% 959
2019
Q4
$2.44M Buy
588,446
+544,636
+1,243% +$2.26M ﹤0.01% 1192
2019
Q3
$132K Buy
+43,810
New +$132K ﹤0.01% 2056
2017
Q4
Sell
-13,248
Closed -$163K 2252
2017
Q3
$163K Sell
13,248
-10,218
-44% -$126K ﹤0.01% 2194
2017
Q2
$386K Sell
23,466
-15,704
-40% -$258K ﹤0.01% 1974
2017
Q1
$562K Sell
39,170
-55,855
-59% -$801K ﹤0.01% 1851
2016
Q4
$1.31M Sell
95,025
-19,134
-17% -$265K ﹤0.01% 1606
2016
Q3
$2.06M Buy
114,159
+11,082
+11% +$200K ﹤0.01% 1402
2016
Q2
$1.48M Buy
103,077
+35,346
+52% +$507K ﹤0.01% 1453
2016
Q1
$809K Sell
67,731
-5,008
-7% -$59.8K ﹤0.01% 1661
2015
Q4
$968K Buy
72,739
+61,174
+529% +$814K ﹤0.01% 1588
2015
Q3
$124K Sell
11,565
-26,303
-69% -$282K ﹤0.01% 2113
2015
Q2
$305K Buy
+37,868
New +$305K ﹤0.01% 1976